Acasă › Limfom folicular › Texas › Houston
Studii clinice pentru Limfom folicular în Houston, TX
18 studii pentru Limfom folicular caută participanți în și în jurul orașului Houston (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
În curs de recrutareStudiu observațional
- Texas Children's Hospital, Houston
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
În curs de recrutareFaza 1/2
- Research Site, Houston
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
În curs de recrutareFaza 1/2
- Md Anderson Cancer Center, Houston
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
În curs de recrutareFaza 1
- Baylor College of Medicine, Houston
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
În curs de recrutareFaza 1
- MD Anderson Cancer Center, Houston
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
În curs de recrutareFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
În curs de recrutareFaza 2
- Research Site, Houston
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
În curs de recrutareFaza 3
- Center for Oncology and Blood Disorders, Houston
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
În curs de recrutareFaza 2
- MD Anderson Cancer Center, Houston
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
În curs de recrutareFaza 2
- M D Anderson Cancer Center, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
În curs de recrutareFaza 3
- MD Anderson Cancer Center, Houston
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
În curs de recrutareFaza 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
În curs de recrutareFaza 1
- The University of TX MD Anderson Cancer Center, Houston
Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
În curs de recrutareFaza 2
- Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston, Houston
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
În curs de recrutareFaza 1
- MD Anderson Cancer Center, Houston
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
În curs de recrutareFaza 1
- MD Anderson Cancer Center, Houston
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
În curs de recrutareFaza 1
- Oncology Consultants, Houston
- University of Texas MD Anderson Cancer Center, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Houston
Studii pentru Limfom folicular în alte orașe
- New York City, NY24 studii
- Milwaukee, WI19 studii
- Nashville, TN18 studii
- Boston, MA17 studii
- Baldwin Park, CA16 studii
- Seattle, WA15 studii
- Durham, NC15 studii
- Columbus, OH13 studii
- Salt Lake City, UT13 studii
- San Antonio, TX12 studii
- Chicago, IL12 studii
- Philadelphia, PA12 studii
Alte studii în Houston
- Cancer pulmonar cu celule non-pătrate145 studii
- Cancer de sân126 studii
- Cancer (toate tipurile)121 studii
- Cancer metastatic104 studii
- Cancer colorectal102 studii
- Cancer ovarian89 studii
- Leucemie mieloasă acută85 studii
- Cancer pulmonar78 studii
- Cancer de prostată76 studii
- Cancer endometrial68 studii
- Cancer pancreatic61 studii
- Melanom59 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.